With reference to the earlier annoucement regarding Q3 results, GlaxoSmithkline Consumer Healthcare Ltd has now informed BSE that there was a typographical error in point no. 1 under NOTES to the financial results which may please be read as follows:
"(1) The Companys nutritional business is India Focused and in a single business and geographical segment. Accordingly segment information is not applicable."
The Company has submitted to BSE a revised copy of the unaudited quarterly financial results of the Company for the quarter ended September 30, 2009.